Why the study?
Does continuous subcutaneous insulin infusion followed by intensified conventional therapy improve peripheral and autonomic nerve dysfunction in type I diabetic patients?
Population
9 type I diabetic patients, aged 18-32 years, with a diabetes duration of 4-23 years and reduced nerve…
Comparison
Continuous subcutaneous insulin infusion for 4… vs Baseline and intra-patient comparison between…
Design
Case_series
Follow-up
Up to 30 weeks (4 weeks CSII + up to 26 weeks ICT)
Authors
Loading...
Transient CSII gains in nerve function may not endure with ICT; leaves open optimal long-term delivery for diabetic neuropathy.
Does continuous subcutaneous insulin infusion followed by intensified conventional therapy improve peripheral and autonomic nerve dysfunction in type I diabetic patients?
Short-term continuous subcutaneous insulin infusion improves peripheral and autonomic nerve function in type 1 diabetes, but these benefits diminish when switching to intensified conventional therapy.
Krönert et al. (1987) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: